
Region:Asia
Author(s):Sanjna
Product Code:KROD5097
November 2024
88

By Product Type: Indias veterinary healthcare market is segmented by product type into pharmaceuticals, diagnostics, and veterinary services. Pharmaceuticals hold a dominant market share, owing to the increasing demand for vaccines, antibiotics, and antiparasitics. The livestock sector's demand for preventive medicines and companion animal owners reliance on pet medications further contribute to this dominance. The rapid rise in zoonotic diseases like avian influenza has also pushed the use of pharmaceuticals to ensure the health of farm animals, thus maintaining a strong market position.

By Animal Type: Indias veterinary healthcare market is segmented by animal type into companion animals, livestock, and aquatic animals. Livestock dominates the market, driven by the nations dependence on agriculture and dairy farming. Livestock farming is a significant contributor to the economy, and the growing demand for high-quality animal products has increased the focus on veterinary healthcare in this segment. Moreover, government initiatives supporting livestock farming and disease control programs for animals have strengthened the importance of livestock in this sector.

The India veterinary healthcare market is dominated by a mix of local and international players. Large multinational companies like Zoetis and Merck Animal Health have strong footholds in the pharmaceuticals and diagnostics segments. Meanwhile, domestic players such as Hester Biosciences and Indian Immunologicals have established strong networks in the livestock health space. The market is consolidated around a few key players, with local manufacturers focusing on specific regions and niches.
|
Company |
Establishment Year |
Headquarters |
No. of Employees |
R&D Spending |
Revenue |
Product Portfolio |
Geographical Reach |
Strategic Collaborations |
|
Zoetis Inc. |
1952 |
New Jersey, USA |
- |
- |
- |
- |
- |
- |
|
Merck Animal Health |
1891 |
New Jersey, USA |
- |
- |
- |
- |
- |
- |
|
Hester Biosciences |
1987 |
Ahmedabad, India |
- |
- |
- |
- |
- |
- |
|
Indian Immunologicals Ltd. |
1982 |
Hyderabad, India |
- |
- |
- |
- |
- |
- |
|
Virbac |
1968 |
Carros, France |
- |
- |
- |
- |
- |
- |
Growth Drivers
Challenges
Over the next five years, the India veterinary healthcare market is expected to experience significant growth, driven by the increasing demand for livestock products, expansion of veterinary diagnostics, and continuous government support for animal health infrastructure. Technological advancements, particularly in diagnostic tools and telemedicine for veterinary services, are expected to further drive market expansion. Moreover, growing pet ownership in urban areas is likely to boost the demand for companion animal healthcare solutions.
Market Opportunities
|
Segments |
Sub-Segments |
|
Product Type |
Pharmaceuticals |
|
Diagnostics |
|
|
Veterinary Services |
|
|
Animal Type |
Companion Animals (Dogs, Cats, Horses) |
|
Livestock (Cattle, Poultry, Swine, Sheep) |
|
|
Aquatic Animals (Fish, Shellfish) |
|
|
Mode of Delivery |
Oral Administration |
|
Injectable |
|
|
Topical |
|
|
End User |
Veterinary Clinics |
|
Veterinary Hospitals |
|
|
Research Institutions |
|
|
Home Care Settings |
|
|
Region |
North |
|
South |
|
|
West |
|
|
East |
1.1. Definition and Scope
1.2. Market Taxonomy
1.3. Market Growth Rate (Compounded Annual Growth Rate, Market Revenue)
1.4. Market Segmentation Overview
2.1. Historical Market Size
2.2. Year-On-Year Growth Analysis
2.3. Key Market Developments and Milestones (Acquisition, Partnerships, Major Investments)
3.1. Growth Drivers
3.1.1. Rising Pet Ownership
3.1.2. Livestock Farming Expansion
3.1.3. Government Initiatives for Animal Health
3.1.4. Increase in Zoonotic Diseases
3.2. Market Challenges
3.2.1. High Cost of Veterinary Medicines
3.2.2. Lack of Veterinary Infrastructure in Rural Areas
3.2.3. Limited Access to Modern Healthcare for Animals
3.3. Opportunities
3.3.1. Growth in Veterinary Diagnostics
3.3.2. Increasing Focus on Companion Animal Health
3.3.3. Technological Advancements in Animal Health Solutions
3.4. Trends
3.4.1. Telemedicine for Veterinary Care
3.4.2. Increasing Demand for Natural and Organic Pet Healthcare Products
3.4.3. Use of AI in Veterinary Diagnostics
3.5. Government Regulation
3.5.1. Regulations on Animal Welfare and Safety
3.5.2. Veterinary Pharmaceuticals and Products Regulations
3.5.3. Standards for Veterinary Clinics and Animal Healthcare Facilities
3.6. SWOT Analysis
3.7. Stakeholder Ecosystem (Veterinarians, Farmers, Pet Owners, Suppliers, Government)
3.8. Porters Five Forces Analysis
3.9. Competition Ecosystem
4.1. By Product Type (In Value %)
4.1.1. Pharmaceuticals (Vaccines, Antibiotics, Antiparasitics)
4.1.2. Diagnostics (Imaging, Molecular Testing, Blood Tests)
4.1.3. Veterinary Services (Clinical Services, Surgical Services, Emergency Care)
4.2. By Animal Type (In Value %)
4.2.1. Companion Animals (Dogs, Cats, Horses)
4.2.2. Livestock (Cattle, Poultry, Swine, Sheep)
4.2.3. Aquatic Animals (Fish, Shellfish)
4.3. By Mode of Delivery (In Value %)
4.3.1. Oral Administration
4.3.2. Injectable
4.3.3. Topical
4.4. By End User (In Value %)
4.4.1. Veterinary Clinics
4.4.2. Veterinary Hospitals
4.4.3. Research Institutions
4.4.4. Home Care Settings
4.5. By Region (In Value %)
4.5.1. North
4.5.2. South
4.5.3. West
4.5.4. East
5.1. Detailed Profiles of Major Companies
5.1.1. Zoetis Inc.
5.1.2. Merck Animal Health
5.1.3. Elanco Animal Health
5.1.4. Boehringer Ingelheim
5.1.5. Virbac
5.1.6. Bayer Animal Health
5.1.7. Vetoquinol SA
5.1.8. Dechra Pharmaceuticals
5.1.9. Hester Biosciences
5.1.10. Indian Immunologicals Ltd.
5.1.11. Neogen Corporation
5.1.12. SeQuent Scientific Ltd.
5.1.13. Intas Pharmaceuticals
5.1.14. Himalaya Animal Healthcare
5.1.15. Zoivane Livestock
5.2. Cross Comparison Parameters (No. of Employees, Headquarters, Inception Year, Revenue, Product Portfolio, R&D Investments, Geographical Presence, Strategic Collaborations)
5.3. Market Share Analysis
5.4. Strategic Initiatives (New Product Launches, Partnerships, Collaborations, Geographical Expansion)
5.5. Mergers and Acquisitions
5.6. Investment Analysis
5.7. Government Grants and Subsidies
5.8. Private Equity Investments
6.1. Animal Health Standards (Mandatory Vaccinations, Disease Control)
6.2. Compliance Requirements for Veterinary Pharmaceuticals
6.3. Certification Processes for Veterinary Products and Services
7.1. Future Market Size Projections
7.2. Key Factors Driving Future Market Growth
8.1. By Product Type (In Value %)
8.2. By Animal Type (In Value %)
8.3. By Mode of Delivery (In Value %)
8.4. By End User (In Value %)
8.5. By Region (In Value %)
9.1. TAM/SAM/SOM Analysis
9.2. Customer Cohort Analysis
9.3. Marketing Initiatives
9.4. White Space Opportunity Analysis
The first step in our research methodology is to identify the key variables influencing the India veterinary healthcare market. This includes comprehensive desk research to gather information from industry stakeholders like veterinary clinics, pharmaceutical companies, and regulatory bodies. Market drivers, challenges, and opportunities are identified during this phase.
During this phase, historical data is analyzed to understand market penetration and trends. We gather data on veterinary services, pharmaceutical sales, and diagnostic tool adoption in both urban and rural regions of India. This helps construct a reliable and accurate market forecast.
We validate our findings through consultations with industry experts, including veterinarians and professionals from leading pharmaceutical companies. This provides insight into market dynamics and the practical aspects of veterinary healthcare.
Finally, we compile the research and provide detailed insights into the India veterinary healthcare market. The data from interviews and expert consultations are cross-verified with secondary sources to ensure accuracy.
The India veterinary healthcare market is valued at USD 500 million, driven by the rising demand for animal health solutions, growing pet ownership, and the need for better livestock care.
The key challenges include high costs of veterinary drugs and diagnostics, lack of advanced veterinary infrastructure in rural areas, and limited access to modern healthcare solutions for animals.
Major players in the market include Zoetis Inc., Merck Animal Health, Hester Biosciences, Indian Immunologicals, and Virbac, all of which have a strong presence due to their extensive product portfolios and market reach.
Growth drivers include the rising awareness of animal health, increasing pet ownership, expanding livestock farming, and advancements in veterinary diagnostics and pharmaceuticals.
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.